Malik M, Tlustos P
Nutrients. 2022; 14(16).
PMID: 36014874
PMC: 9415189.
DOI: 10.3390/nu14163367.
Satoh R, Kawakami K, Nakadate K
J Clin Med. 2022; 11(12).
PMID: 35743382
PMC: 9224974.
DOI: 10.3390/jcm11123310.
Mali K, V Sutar G, Dias R, Devade O
Turk J Pharm Sci. 2021; 18(1):3-9.
PMID: 33631923
PMC: 7957316.
DOI: 10.4274/tjps.galenos.2019.30316.
Kouga T, Koizume S, Aoki S, Jimbo E, Yamagata T, Inoue K
Mol Genet Metab Rep. 2019; 20:100474.
PMID: 31110947
PMC: 6510973.
DOI: 10.1016/j.ymgmr.2019.100474.
Arhami Dolatabadi A, Larimi S, Safaie A
Arch Acad Emerg Med. 2019; 7(1):e9.
PMID: 30847444
PMC: 6377226.
The Conditions Under Which Piracetam Is Used and the Factors That Can Improve National Institute of Health Stroke Scale Score in Ischemic Stroke Patients and the Importance of Previously Unnoticed Factors From a Hospital-Based Observational Study in....
Chen S, Liu J, Wang Y, Huang J, Chen S, Yang S
J Clin Med. 2019; 8(1).
PMID: 30669522
PMC: 6351917.
DOI: 10.3390/jcm8010122.
The Effect of Agomelatine Treatment on Diabetes-Induced Cognitive Impairments in Rats: Concomitant Alterations in the Hippocampal Neuron Numbers.
Can O, Ucel U, Ozkay U, Ulupinar E
Int J Mol Sci. 2018; 19(8).
PMID: 30127276
PMC: 6121488.
DOI: 10.3390/ijms19082461.
Metabolic Enhancer Piracetam Attenuates the Translocation of Mitochondrion-Specific Proteins of Caspase-Independent Pathway, Poly [ADP-Ribose] Polymerase 1 Up-regulation and Oxidative DNA Fragmentation.
Verma D, Gupta S, Biswas J, Joshi N, Raju K, Wahajuddin M
Neurotox Res. 2018; 34(2):198-219.
PMID: 29532444
DOI: 10.1007/s12640-018-9878-2.
Pharmacokinetic Study of Piracetam in Focal Cerebral Ischemic Rats.
Paliwal P, Dash D, Krishnamurthy S
Eur J Drug Metab Pharmacokinet. 2017; 43(2):205-213.
PMID: 28916907
DOI: 10.1007/s13318-017-0435-9.
Establishing Natural Nootropics: Recent Molecular Enhancement Influenced by Natural Nootropic.
Suliman N, Taib C, Mohd Moklas M, Adenan M, Hidayat Baharuldin M, Basir R
Evid Based Complement Alternat Med. 2016; 2016:4391375.
PMID: 27656235
PMC: 5021479.
DOI: 10.1155/2016/4391375.
A drug utilization study of cognition enhancers in dementia in a tertiary care hospital in mumbai.
Thakkar K, Suman S, Billa G
J Clin Diagn Res. 2014; 8(5):HC05-8.
PMID: 24995193
PMC: 4080014.
DOI: 10.7860/JCDR/2014/7998.4354.
Effects of piracetam on pediatric breath holding spells: a randomized double blind controlled trial.
Abbaskhanian A, Ehteshami S, Sajjadi S, Rezai M
Iran J Child Neurol. 2014; 6(4):9-15.
PMID: 24665274
PMC: 3943019.
Augmented memory: a survey of the approaches to remembering more.
Madan C
Front Syst Neurosci. 2014; 8:30.
PMID: 24624063
PMC: 3939671.
DOI: 10.3389/fnsys.2014.00030.
Effect of piracetam on the cognitive performance of patients undergoing coronary bypass surgery: A meta-analysis.
Fang Y, Qiu Z, Hu W, Yang J, Yi X, Huang L
Exp Ther Med. 2014; 7(2):429-434.
PMID: 24396419
PMC: 3881046.
DOI: 10.3892/etm.2013.1425.
Protective effect of Bajijiasu against β-amyloid-induced neurotoxicity in PC12 cells.
Chen D, Zhang P, Lin L, Shuai O, Zhang H, Liu S
Cell Mol Neurobiol. 2013; 33(6):837-50.
PMID: 23812758
PMC: 11497914.
DOI: 10.1007/s10571-013-9950-7.
The developing utility of zebrafish models for cognitive enhancers research.
Stewart A, Kalueff A
Curr Neuropharmacol. 2013; 10(3):263-71.
PMID: 23449968
PMC: 3468880.
DOI: 10.2174/157015912803217323.
Double-blind, placebo-controlled trial on the effect of piracetam on breath-holding spells.
Sawires H, Botrous O
Eur J Pediatr. 2012; 171(7):1063-7.
PMID: 22302459
DOI: 10.1007/s00431-012-1680-1.